---
title: "Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT"
ocid: "ocds-h6vhtk-0335bf"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0335bf"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0335bf.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0335bf.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "BELFAST HEALTH AND SOCIAL CARE TRUST"
published: "2022-05-09"
---

# Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT

Buyer: BELFAST HEALTH AND SOCIAL CARE TRUST  
Current stage: Award  
OCID: ocds-h6vhtk-0335bf

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0335bf)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0335bf.json)

## Summary

The Belfast Health and Social Care Trust has successfully completed a procurement process for the acquisition of Lutetium (177Lu) oxodetreotide, known commercially as Luthathera, which is a radiopharmaceutical used in the treatment of specific neuroendocrine tumours. Classified under the medical equipment and pharmaceuticals industry, this tender was executed through a limited procurement method, specifically negotiated without publication of a contract notice. The contract, valued at £1,000,000, was signed on the 9th of May 2022, and the delivery is set to take place at Belfast Health and Social Care Trust facilities in the UK.

This procurement presents significant business growth opportunities, particularly for companies specialising in medical equipment and pharmaceuticals, especially those with a focus on unique or patented products. Given the exclusive nature of the supply—through Advanced Accelerator Applications (UK & Ireland) Ltd, the sole license holder for this therapy—businesses with advanced capabilities in radiopharmaceuticals or related fields may find it beneficial to explore partnerships or innovations that align with the healthcare sector's needs. Companies in the broader health supply chain seeking to expand their market presence could also leverage this type of opportunity for future contract considerations.

## Notice

Procurement of Lutetium (177Lu) oxodetreotide (Luthathera) PRRT

### Procurement Information

No other reasonable alternative or substitute exists for this procurement and the absence of competition is not a result of the artificial narrowing of the parameters of the procurement. Lutetium (177Lu) oxodetreotide (Lutathera) is a licensed radiopharmaceutical for the treatment of unresectable or metastatic, progressive, well-differentiated somatostatin receptor positive gastro-entero-pancreatic neuroendocrine (GEP) tumours in adults. The supplier, Advanced Accelerator Applications (AAA), holds the unique patent and licence for this product. This is the only licenced Peptide Receptor Radionuclide Therapy (PRRT) in Europe.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/012066-2022 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Negotiated without publication of a contract notice |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 9 May 2022 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 8 May 2022 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £1,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | BELFAST HEALTH AND SOCIAL CARE TRUST |
| Locality | BELFAST |
| Post town | Northern Ireland |
| Postcode | BT9 7AB |
| Country | Northern Ireland |
| ITL 1 | TLN Northern Ireland |
| ITL 2 | TLN0 Northern Ireland |
| ITL 3 | TLN06 Belfast |
| Local authority | Belfast |
| Electoral ward | Blackstaff |
| Westminster constituency | Belfast South and Mid Down |
| Delivery location | TLN Northern Ireland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | ADVANCED ACCELERATOR APPLICATIONS (UK & IRELAND |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33000000 - Medical equipments, pharmaceuticals and personal care products

## Release History

- 9 May 2022 at 16:52 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/012066-2022

## Notice URLs

- http://www.adacap.com
- https://belfasttrust.hscni.net

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0335bf. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0335bf.json.